Clinical trials - Press Releases

Date	Title	Company
10-Dec-2019	Autolus Therapeutics Announces New Data Showcasing Clinical Progress of AUTO3 in B Cell Malignancies	Autolus Therapeutics plc
10-Dec-2019	KITE, A GILEAD COMPANY, ANNOUNCES LONG-TERM DATA FROM ZUMA-1 SHOWING 47% OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA PATIENTS WERE ALIVE THREE YEARS AFTER YESCARTA® (AXICABTAGENE CILOLEUCEL) TREATMENT	Kite, a Gilead Company
10-Dec-2019	Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers	Autolus Therapeutics plc
10-Dec-2019	XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen	XBiotech
10-Dec-2019	Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis	Galderma
10-Dec-2019	Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa	Abeona Therapeutics Inc
10-Dec-2019	Acalabrutinib (Calquence) significantly prolonged the time patients lived without disease progression or death in previously untreated chronic lymphocytic leukaemia	AstraZeneca
10-Dec-2019	The partnership will provide strategic consulting for life sciences and healthcare companies & providers in Europe	PharmaLex Group
10-Dec-2019	Upperton is Launching an Enabling Technology Screening Protocol	Upperton Pharma Solutions
10-Dec-2019	Precipice Design Reimagines NIOX VERO® Asthma Detection and Management System	Precipice Design
10-Dec-2019	bluebird bio and Bristol-Myers Squibb Present Updated Data from Ongoing Phase 1 Study of BCMA-Targeted CAR T Cell Therapy bb21217 in Relapsed/Refractory Multiple Myeloma at 61st ASH Annual Meeting and Exposition	Bristol-Myers Squibb
10-Dec-2019	Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen	Genmab A/S
10-Dec-2019	Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US	Inceptua
09-Dec-2019	The Alliance for Regenerative Medicine to host European ATMP Access Meeting in Brussels	The Alliance for Regenerative Medicine
09-Dec-2019	Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®	UCB
09-Dec-2019	ReNeuron Group plc - Interim Results	ReNeuron Group plc
09-Dec-2019	Professor Amit Nathwani will present the Ham-Wasserman Lecture at the 61st ASH Annual Meeting	Freeline
09-Dec-2019	BC Platforms Partners with leading European Genomics Service Provider Life & Brain to Expand Genotyping Services Across Europe	BC Platforms
09-Dec-2019	UKCPA publish recommendations to avoid errors with Syntocinon® & Syntometrine®	UKCPA
09-Dec-2019	Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®	UCB